nach oben

Quality of Life Research

Erschienen in:

01.08.2007 | Original Paper

Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

verfasst von: Meryl Brod, Torsten Christensen, Donald Bushnell

Erschienen in: Quality of Life Research | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Variables associated with treatment satisfaction (TS) can be broadly categorized as precursors, ongoing treatment issues, and treatment outcomes. This study continues the validation process for the Insulin Treatment Satisfaction Questionnaire (ITSQ) while examining relationships between TS and these broader influences.

Methods

Data (N = 299) were collected in a RCT comparing safety and efficacy of inhaled vs. injectable insulin. Validation examined item and factor characteristics, reliability and validity. Regression analyses examined relationships between overall and domain specific TS and the broader influences.

Results

Patients with less previous or current treatment burden had greater TS (p < 0.001). Gender, injection fear, functioning, age, compliance and glycemic control were differentially related to TS at the beginning and end of study. Baseline satisfaction was predictive of future TS (p < 0.001). When all significant factors were examined together, lower burden with the current treatment and higher satisfaction with previous treatment continued to be key (p < 0.001) while other factors were no longer significant. Validation findings confirmed the ITSQ was psychometrically sound.

Conclusion

Over the course of treatment, some factors are associated with TS at treatment start while others are key drivers at treatment end. This suggests that TS is not a static concept.

Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.CrossRef

UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837–853.

Weaver, M., Patrick, D. L., Markson, L. E., Martin, D., Frederic, I., & Berger, M. (1997). Issues in the measurement of satisfaction with treatment. American Journal of Managed Care, 3, 579–594.PubMed

Cappelleri, J. C., Gerber, R. A., Kourides, I. A., & Gelfand, R. A. (2000). Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care, 23, 1799–1803.PubMedCrossRef

Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with Type 2 diabetes. Diabetes Care, 25, 458–463.PubMedCrossRef

Taylor, M. D., Frier, B. M., Gold, A. E., & Beary, I. J. (2003). Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: the Edinburgh prospective diabetes study. Diabetes Medicine, 20, 135–146.CrossRef

Ahlgren, S. S., Shultz, J. A., Massey, L. K., Hicks, B. C., & Wysham, C. (2004) Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Quality of Life Research, 13, 819–832.PubMedCrossRef

Anderson, R. T., Skovlund, S. E., Marrero, D., Levine, D. W., Meadows, K., Brod, M., & Balkrishnan, R. (2004). Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics, 26, 565–578.PubMedCrossRef

Royle, P., Waugh, N., McAuley, L., McIntyre, L., & Thomas, S. (2003). Inhaled insulin in diabetes mellitus. The Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD003890.pub.2.

10.

Atkinson, M. J., Kumar, R., Cappelleri, J. C., & Hass, S. L. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version ll) among outpatient pharmacy consumers. Value in Health, 8(1), 9–24.CrossRef

11.

Dunbar-Jacob, J., & Mortimer-Stephens, M. K. (2001). Treatment adherence in chronic disease. Journal of Clinical Epidemiology, 54 (Suppl 1), S57–S60 (Review).

12.

Robiner, W. N. (2005). Enhancing adherence in clinical research. Contemporary Clinical Trials, 26(1), 59–77 (Review).

13.

Piette, J. D., Wagner, T. H., & Potter, M. B., et al. (2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109.PubMedCrossRef

14.

Haynes, R. B., McKibbon, K. A., & Kanani, R. (1996). Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348(9024), 383–386.PubMedCrossRef

15.

Leo, R. J., Jassal, K., & Badhai, Y. D. (2005). Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry, 12(6), 33–39.

16.

Gerber, R. A, Cappelleri, J. C, Kourides, I. A., & Gelfand, R. A. (2001). Treatment satisfaction with inhaled insulin in patients with type 1 diabetes. Diabetes Care, 24, 1556–1559.PubMedCrossRef

17.

Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J., & Levin, S. R. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care, 27, 2356–2362.PubMedCrossRef

18.

Quattrin, T., Belanger, A., Bohannon, N. J. V., & Schwartz, S. L. (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care, 27, 2622–2627.PubMedCrossRef

19.

Rosenstock, J., Cappelleri, J. C., Bolinder, B., & Gerber, R. A. (2004). Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care, 27, 1318–1323.PubMedCrossRef

20.

Raskin, P., Bode, B. W., Marks, J. B., Hirsch, I. B., Weinstein, R. L., McGill J. B., Peterson, G. E., Mudaliar, S. R., & Reinhardt, R. R. (2003). Continuous subcutaneous insulin infusion and multiple daily injection therapy and equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care, 26, 2598–2603.PubMedCrossRef

21.

Weintrob, N., Benzaquen, H., Galatzer, A., Shalitin, S., Lazar, L., Fayman, G., Lilos, P., Dickerman, Z., & Phillip, M. (2002). Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics, 112, 559–564.CrossRef

22.

Bott, U., Ebrahim, S., Hirchberger, S., & Skovlund, S. E. (2003). Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetes Medicine, 20, 626–634.CrossRef

23.

Renner, R., Pfutzner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999). Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care, 22, 784–788.PubMedCrossRef

24.

DeVries J. H., Snoek, F. J., Kostense, P. J., Masurel, N., & Heine, R. J. (2002). A randomized trial of continuous subcutaneous insulin infrion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care, 25, 2074–2080.PubMedCrossRef

25.

Herman, W. H., Ilag, L. L., Johnson, S. L., Martin, C. L., Sinding, J., Al Harthi, A., Plunkett, C. D., LaPorte F. B., Burke, R., Brown, M. B., Halter, J. B., & Raskin, P. (2005). A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 28, 1568–1573.PubMedCrossRef

26.

Janssen, M. M. J., Snoek, F. J., Masurel, N., Hoogma, R. P. L. M., Deville, W. L., Popp-Snijders, C., & Heine, R. J. (2000). Optimized based-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients. Diabetes Care, 23, 629–633.PubMedCrossRef

27.

Bech, P., Moses, R., & Gomis, R. (2003). The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: A placebo-controlled, multicenter study. Quality of Life Research, 12, 413–425.PubMedCrossRef

28.

Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., & Rowland, C. (2004). Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12–25.PubMedCrossRef

29.

Moses, R., Clauson, P., Vesterager, A., Roberts, A., & Wollmer, P. (2006). Inhaled preprandial human insulin (AERx iDMS) versus subcutaneous insulin aspart in type 1 diabetes. Poster presentation IDF, Cape Town, South Africa.

30.

Snoek, F. J., Mollema, E. D., Heine, R. J., Bouter, L. M., & van der Ploeg, H. M. (1997). Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): First findings. Diabetes Medicine, 14, 871–876.CrossRef

31.

Mollema, E., Snoek, F., Pouwer, F., Heine, R., & Van Der Ploeg, H. (2000). Diabetes fear of injecting and self-testing questionnaire. Diabetes Care, 23(6), 765–769.

32.

Kramer, J. (2006). The diabetes medication compliance scale (DMCS), measure under development.

33.

Anderson, R., Skovlund, S. E., Marrero, D., & Schwartz, S. (2003). Self-reported non-adherence with insulin injection therapy in people with type 1 and 2 diabetes. Poster presentation IDF, Paris, France.

34.

Welch, G. W., Weinger, K., Anderson, B., & Polonsky, W. H. (2003). Responsiveness of the problem areas in diabetes (PAID) questionnaire. Diabetic Medicine, 20, 69–72.PubMedCrossRef

35.

Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997). The problem areas in diabetes scale: An evaluation of its clinical utility. Diabetes Care, 20, 760–766.PubMedCrossRef

36.

Ware, J. Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medicine Care, 34, 220–233.CrossRef

37.

Turner-Bowker, D. M., Bartley, P. J., & Ware, J. E. Jr. (2002). SF-36® health survey & “SF” bibliography: Third edition (1988–2000). Lincoln, RI: QualityMetric Incorporated.

38.

Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, Incorporated.

39.

Cronbach, L. F. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef

40.

Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.CrossRef

41.

Brod, M., Skovlund, S. E., & Wittrup-Jensen, K. (2006). Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research, 15, 481–491.PubMedCrossRef

42.

Brod, M., Mendelson, G., & Roberts, B. (1998). Patient’s experience of Parkinson’s disease. Journal of Gerontology, 53B(4), 213–222.

Titel: Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes
verfasst von: Meryl Brod
Torsten Christensen
Donald Bushnell
Publikationsdatum: 01.08.2007
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 6/2007
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-007-9209-1

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2007

Psychometric properties of the Minnesota Living with Heart Failure—Brazilian version—in the elderly

‘Translation is not enough’: using the Global Person Generated Index (GPGI) to assess individual quality of life in Bangladesh, Thailand, and Ethiopia

Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis

Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report

Health related quality of life in different states of breast cancer

Effect of trauma on quality of life as mediated by mental distress and moderated by coping and social support among postconflict displaced Ethiopians